Oncology Convention returns to the NEC, Birmingham, 15th & 16th of September, 2021
ROAR B2B are pleased to announce that on the 15th and 16th of September this year, Oncology Convention will be returning to the physical space. Having hosted a virtual event during the last lockdown, there was a large appetite for a return to face-to-face events. The Oncology Convention will become one of the first UK-based oncology conventions to be hosted following the outbreak of COVID-19.
Bradley Maule-ffinch, Group Managing Director, commented “During the pandemic, we kept our events going with virtual alternatives, but we know that our speakers, exhibitors and visitors have been keen to get back together in the physical space. That is why we’re so pleased to be able to bring Oncology Convention back to the Birmingham NEC this year. The oncology community thrives in gatherings like this and after a year off, our next event is sure to be something special.”
A key aspect of the upcoming event will be the seminar programme. These seminars will be given by a range of expert speakers, each of them coming from a different part of the cancer-care process, but all of them united in their goal to provide the best outcomes for people with cancer. Speakers include surgeons who are experienced in removing tumours, technical experts who are developing new technologies to treat cancers and frontline healthcare providers who help to maintain the wellbeing of patients before, during and after treatment. All seminar sessions are CPD accredited.
ROAR B2B have also collaborated with Rutherford Cancer Centres in order to provide a series of Masterclasses. These are advanced sessions made to provide oncology professionals with valuable insights and clear learning outcomes which will benefit their day-to-day jobs in tangible ways.
On top of the speakers and seminars at Oncology Convention, the event will also provide industry professionals with an opportunity to get a look at some of the latest pieces of technology being developed to benefit oncologists and people with cancer. With networking opportunities also available, the event will facilitate the formation of many valuable professional relationships, as well being as a driving force for new ideas and the advancement of the oncology field.